Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Bright Disease

arginyl-glycyl-aspartic acid has been researched along with Bright Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amann, K; Daniel, C; Haas, CS; Hartner, A; Schöcklmann, HO; Schüssler, J1
Fischer, EG1

Other Studies

2 other study(ies) available for arginyl-glycyl-aspartic acid and Bright Disease

ArticleYear
Beneficial effects of integrin αvβ3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:5

    Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Creatinine; Crotalid Venoms; Disease Models, Animal; Dose-Response Relationship, Drug; Glomerulonephritis; In Vitro Techniques; Integrin alphaVbeta3; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; Oligopeptides; Time Factors

2012
Glomerular mesangial cell adhesion to fibrinogen is mediated by alphavbeta3 integrin.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 2004, Volume: 82, Issue:5

    Topics: Animals; Cell Adhesion; Cells, Cultured; Extracellular Matrix Proteins; Fibrinogen; Glomerular Mesangium; Glomerulonephritis; Integrin alphaVbeta3; Oligopeptides; Protein Binding; Rats

2004